Research output per year
Research output per year
Personal profile
Expertises
For NSCLC, especially for genomic defined subtypes (ALK positive and EGFR mutated). Besides for Malign Pleural Mesotheliom, SCLC/NEC and palliative care.
Main research areas
Genomic defined NSCLC
Current research
Genomic research project about molecular status af ALK positive NSCLC
Potential conflicts of interest
Had in the past received honoraria from Pfizer A/S. No conflicts curently.
Fingerprint
Dive into the research topics where Edyta Maria Urbanska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?
Urbanska, E. M., Sørensen, J. B. & Santoni-Rugiu, E., Mar 2023, In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 18, 3, p. e28-e29Research output: Contribution to journal › Letter › peer-review
-
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC
Urbanska, E. M., Grauslund, M., Koffeldt, P. R., Truelsen, S. L. B., Löfgren, J. O., Costa, J. C., Melchior, L. C., Sørensen, J. B. & Santoni-Rugiu, E., 23 Aug 2023, In: International Journal of Molecular Sciences. 24, 17Research output: Contribution to journal › Journal article › Research › peer-review
-
Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non-Small-Cell Lung Cancer
Urbanska, E. M., Sørensen, J. B., Melchior, L. C., Costa, J. C. & Santoni-Rugiu, E., Jul 2022, In: JCO Precision Oncology. 6, p. e2200040Research output: Contribution to journal › Journal article › Research › peer-review
-
Affiliation to the Labour Market in Denmark for Patients Under 60 Years of Age After Diagnosis and Treatment for ALK-Positive NSCLC
Urbanska, E., 2021, p. S1000-S1001.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
Impact of Real-World DNA- and RNA-Based Rebiopsy Testing in EGFR-Mutated NSCLC Progressing on Osimertinib
Urbanska, E., Sørensen, J. B., Melchior, L. & Santoni-Rugiu, E., 2021, In: Journal of Thoracic Oncology. 16, Supplement 10, p. S1093-S1094Research output: Contribution to journal › Conference abstract in journal › Research › peer-review